肺恶性瘤通过空气空间传播的极性的动态变化
Yoshiaki Matsuura1,2, Kunishige Onuma1, Roberto Coppo1
1Department of Clinical Bio-resource Research and Development, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
The Journal of pathology
|January 13, 2025
概括
通过空气空间传播 (STAS) 涉及肺空气空间中的瘤细胞,影响预后. 这项研究表明,极性切换,特别是顶膜损失,以及TGF-β1诱导的FSTL1促进肺癌中STAS的进展.
科学领域:
- 在瘤学瘤学.
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
背景情况:
- 通过空气空间传播 (STAS) 是肺癌的一个组织学特征,其病理生物学不清楚.
- STAS是肺恶性瘤的重要预后因素.
研究的目的:
- 通过分析STAS和极性切换之间的关系来研究STAS的机制.
- 阐明转化生长因子β1 (TGF-β1) 和类蛋白1 (FSTL1) 在STAS进展中的作用.
主要方法:
- 肺转移和腺癌中STAS病变的组织病理学分析.
- 在小鼠体内注射角外结直肠癌 (CRC) 器官.
- 在STAS的体外共同培养模型中使用癌细胞器官和小鼠呼吸道上皮细胞器官 (2D-MAO).
- 用TGF-β1刺激呼吸道上皮,并分析基因表达.
主要成果:
- 在STAS病变之外观察到状膜.
- 在外的CRC有机体在体内表现出更大的转移潜力.
- 癌症器官对呼吸道上皮质的粘附涉及到顶膜的损失.
- TGF-β1刺激通过FSTL1诱导增强了CRC器官粘附,促进了顶峰膜损失.
结论:
- 极性切换,特别是顶膜损失,对于STAS形成至关重要.
- 在气道上皮质中TGF-β1诱导的FSTL1通过改变癌细胞极性来促进STAS的进展.
- 了解STAS机制可以改善肺癌患者的存活率.
相关概念视频
01:27Pneumothorax-II
120
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
120
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:17Other Pulmonary Disorders
801
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
801
01:26Pneumothorax-I
169
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
169
01:19Factors Affecting Pulmonary Ventilation
1.1K
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
1.1K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K